|
|
Blood, 1 September 2006, Vol. 108, No. 5, pp. 1770-1773.
Prepublished online as a Blood First Edition Paper on May 4, 2006; DOI 10.1182/blood-2005-10-006536.
Previous Article | Next Article 
Submitted October 25, 2005
Accepted April 18, 2006
In vitro priming and expansion of cytomegalovirus-
specific Th1 and Tc1 T cells from naive Cord Blood
lymphocytes
Kyung-Duk Park, Luciana Marti, Joanne Kurtzberg, and Paul Szabolcs*
Department of Pediatrics, Pediatric Blood and Marrow Transplant Program, Duke University, Durham, NC
* Corresponding author; email: szabo001{at}mc.duke.edu.
Adoptive transfer of CMV-specific cytotoxic T cells (CTL) expanded in vitro from memory donor T cells can reduce the incidence of CMV disease in allogeneic transplant recipients. However, this approach has been unavailable in the cord blood (CB) transplant setting because CB T cells are antigen-naïve and biased towards Th2/Tc2 function. We developed a protocol to in vitro prime and expand CMV-specific CTL from CB. T cells were primed with cytokines to trigger skewing towards Th1/Tc1 lineage before encountering monocyte and CD34+ progenitor-derived dendritic cells loaded with CMV-antigen and its immune complex. CMV-pulsed cultures expanded significantly more over 4-6 weeks than CMV- cultures despite identical cytokine milieu. T cells isolated from CMV+ cultures showed a preferential expansion of CD45RA-/RO+/CD27+ T cells compared to CMV- cultures. CMV-specific IFN and TNF producing CD4+ (Th1) and CD8+ (Tc1) T cells were enriched after 3-4 weeks and CMV-specific cytotoxicity developed 1-2 weeks later.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. W. Childs and C. S. Zerbe
Expanding multiviral reactive T cells from cord blood
Blood,
August 27, 2009;
114(9):
1725 - 1726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Hanley, C. R. Y. Cruz, B. Savoldo, A. M. Leen, M. Stanojevic, M. Khalil, W. Decker, J. J. Molldrem, H. Liu, A. P. Gee, et al.
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes
Blood,
August 27, 2009;
114(9):
1958 - 1967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Colleton, X.-L. Huang, N. M. Melhem, Z. Fan, L. Borowski, G. Rappocciolo, and C. R. Rinaldo
Primary Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses Induced by Myeloid Dendritic Cells
J. Virol.,
June 15, 2009;
83(12):
6288 - 6299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. V. Komanduri, L. S. St. John, M. de Lima, J. McMannis, S. Rosinski, I. McNiece, S. G. Bryan, I. Kaur, S. Martin, E. D. Wieder, et al.
Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing
Blood,
December 15, 2007;
110(13):
4543 - 4551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Barker
Umbilical Cord Blood (UCB) Transplantation: An Alternative to the Use of Unrelated Volunteer Donors?
Hematology,
January 1, 2007;
2007(1):
55 - 61.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|